Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Income Statement

GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Income Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
INCOME :
Gross Sales ₹28,707 Cr₹27,709 Cr₹28,219 Cr₹27,805 Cr₹25,241 Cr
     Sales ₹28,418 Cr₹27,403 Cr₹27,990 Cr₹27,665 Cr₹25,094 Cr
     Job Work/ Contract Receipts -----
     Processing Charges / Service Income ₹113 Cr₹129 Cr₹78 Cr₹8.49 Cr₹8.93 Cr
     Revenue from property development -----
     Other Operational Income ₹176 Cr₹178 Cr₹151 Cr₹131 Cr₹138 Cr
Less: Excise Duty -----
Net Sales ₹13,322 Cr₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹-214 Cr₹-196 Cr₹-241 Cr₹-11 Cr₹-189 Cr
Raw Material Consumed ₹4,501 Cr₹4,548 Cr₹4,445 Cr₹4,323 Cr₹3,809 Cr
     Opening Raw Materials ₹580 Cr₹649 Cr₹703 Cr₹528 Cr₹635 Cr
     Purchases Raw Materials ₹3,188 Cr₹3,027 Cr₹3,078 Cr₹3,380 Cr₹2,952 Cr
     Closing Raw Materials ₹832 Cr₹580 Cr₹649 Cr₹703 Cr₹528 Cr
     Other Direct Purchases / Brought in cost ₹1,566 Cr₹1,451 Cr₹1,312 Cr₹1,118 Cr₹750 Cr
     Other raw material cost -----
Power & Fuel Cost ₹131 Cr₹124 Cr₹112 Cr₹201 Cr₹165 Cr
     Electricity & Power ₹131 Cr₹124 Cr₹112 Cr₹201 Cr₹165 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹3,022 Cr₹2,868 Cr₹2,601 Cr₹2,447 Cr₹2,344 Cr
     Salaries, Wages & Bonus ₹2,780 Cr₹2,641 Cr₹2,393 Cr₹2,238 Cr₹2,160 Cr
     Contributions to EPF & Pension Funds ₹217 Cr₹204 Cr₹187 Cr₹184 Cr₹165 Cr
     Workmen and Staff Welfare Expenses ₹25 Cr₹24 Cr₹17 Cr₹17 Cr₹17 Cr
     Other Employees Cost --₹3.59 Cr₹7.92 Cr₹1.85 Cr
Other Manufacturing Expenses ₹768 Cr₹1,013 Cr₹634 Cr₹785 Cr₹639 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges ₹126 Cr₹121 Cr₹98 Cr₹156 Cr₹114 Cr
     Repairs and Maintenance ₹172 Cr₹166 Cr₹153 Cr₹163 Cr₹148 Cr
     Packing Material Consumed -----
     Other Mfg Exp ₹470 Cr₹727 Cr₹382 Cr₹466 Cr₹376 Cr
General and Administration Expenses ₹1,457 Cr₹1,314 Cr₹1,212 Cr₹1,265 Cr₹1,028 Cr
     Rent , Rates & Taxes ₹77 Cr₹69 Cr₹66 Cr₹63 Cr₹77 Cr
     Insurance ₹44 Cr₹36 Cr₹37 Cr₹34 Cr₹30 Cr
     Printing and stationery -----
     Professional and legal fees ₹276 Cr₹210 Cr₹244 Cr₹353 Cr₹269 Cr
     Traveling and conveyance ₹292 Cr₹283 Cr₹254 Cr₹182 Cr₹116 Cr
     Other Administration ₹768 Cr₹715 Cr₹612 Cr₹633 Cr₹536 Cr
Selling and Distribution Expenses ₹1,271 Cr₹893 Cr₹1,137 Cr₹896 Cr₹943 Cr
     Advertisement & Sales Promotion ₹827 Cr₹516 Cr₹693 Cr₹543 Cr₹551 Cr
     Sales Commissions & Incentives -----
     Freight and Forwarding ₹443 Cr₹377 Cr₹444 Cr₹353 Cr₹393 Cr
     Handling and Clearing Charges -----
     Other Selling Expenses -----
Miscellaneous Expenses ₹34 Cr₹54 Cr₹48 Cr₹79 Cr₹121 Cr
     Bad debts /advances written off -₹18 Cr₹13 Cr--
     Provision for doubtful debts ₹3.10 Cr--₹30 Cr₹11 Cr
     Losson disposal of fixed assets(net) ---₹6.46 Cr-
     Losson foreign exchange fluctuations ----₹75 Cr
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹31 Cr₹37 Cr₹35 Cr₹42 Cr₹35 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹10,970 Cr₹10,618 Cr₹9,948 Cr₹9,985 Cr₹8,860 Cr
Operating Profit (Excl OI) ₹2,351 Cr₹1,195 Cr₹1,635 Cr₹2,320 Cr₹2,084 Cr
Other Income ₹114 Cr₹840 Cr₹289 Cr₹167 Cr₹50 Cr
     Interest Received ₹44 Cr₹6.18 Cr₹7.00 Cr₹9.44 Cr₹2.65 Cr
     Dividend Received ₹0.01 Cr₹0.00 Cr₹0.35 Cr₹0.35 Cr₹0.35 Cr
     Profit on sale of Fixed Assets -₹1.53 Cr₹5.73 Cr-₹0.35 Cr
     Profits on sale of Investments -----
     Provision Written Back -----
     Foreign Exchange Gains ₹28 Cr-₹203 Cr₹88 Cr-
     Others ₹42 Cr₹832 Cr₹72 Cr₹69 Cr₹47 Cr
Operating Profit ₹2,465 Cr₹2,035 Cr₹1,924 Cr₹2,487 Cr₹2,135 Cr
Interest ₹207 Cr₹516 Cr₹349 Cr₹298 Cr₹353 Cr
     InterestonDebenture / Bonds --₹2.38 Cr₹32 Cr₹93 Cr
     Interest on Term Loan ₹153 Cr₹461 Cr₹141 Cr₹51 Cr₹86 Cr
     Intereston Fixed deposits -----
     Bank Charges etc -----
     Other Interest ₹54 Cr₹55 Cr₹206 Cr₹215 Cr₹174 Cr
PBDT ₹2,258 Cr₹1,519 Cr₹1,575 Cr₹2,189 Cr₹1,781 Cr
Depreciation ₹486 Cr₹582 Cr₹569 Cr₹487 Cr₹444 Cr
Profit Before Taxation & Exceptional Items ₹1,772 Cr₹937 Cr₹1,006 Cr₹1,702 Cr₹1,338 Cr
Exceptional Income / Expenses ₹-373 Cr₹-901 Cr₹-766 Cr₹-261 Cr₹45 Cr
Profit Before Tax ₹1,399 Cr₹36 Cr₹240 Cr₹1,441 Cr₹1,382 Cr
Provision for Tax ₹352 Cr₹1,867 Cr₹329 Cr₹448 Cr₹412 Cr
     Current Income Tax ₹382 Cr₹1,116 Cr₹416 Cr₹547 Cr₹498 Cr
     Deferred Tax ₹-315 Cr₹314 Cr₹-349 Cr₹-87 Cr₹-60 Cr
     Other taxes ₹285 Cr₹438 Cr₹263 Cr₹-12 Cr₹-26 Cr
Profit After Tax ₹1,047 Cr₹-1,831 Cr₹-90 Cr₹994 Cr₹970 Cr
Extra items -₹397 Cr₹467 Cr--
Minority Interest ₹-0.05 Cr₹-68 Cr₹-80 Cr₹-52 Cr₹-0.05 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹1,047 Cr₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr
Adjustments to PAT -----
Profit Balance B/F ₹7,870 Cr₹9,457 Cr₹9,211 Cr₹7,234 Cr₹6,330 Cr
Appropriations ₹8,918 Cr₹7,955 Cr₹9,508 Cr₹8,175 Cr₹7,300 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹119 Cr₹85 Cr₹51 Cr₹-1,036 Cr₹66 Cr
Equity Dividend % ₹250.00₹250.00₹250.00₹250.00₹250.00
Earnings Per Share ₹37.11₹-53.21₹10.53₹33.37₹34.38
Adjusted EPS ₹37.11₹-53.21₹10.53₹33.37₹34.38

Compare Income Statement of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,639.7 Cr 1.6% 4% 15.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,675.0 Cr -3% -2.6% 21.3% Stock Analytics
DIVIS LABORATORIES ₹225,516.0 Cr -0.5% 17% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,190.0 Cr 0.6% 2.7% 35.5% Stock Analytics
CIPLA ₹115,523.0 Cr -2.2% 0.8% -2.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,493.4 Cr -1.1% -1.6% -0.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.6%

4%

15.9%

SENSEX

-1%

0.7%

-3.6%


You may also like the below Video Courses